BioSpace News Archive

Synergy Laboratories (Synergy) is adding a new testing platform to augment its vital COVID-19 diagnostic capabilities. Over the last 8 weeks Synergy has been able to serve first line responders, healthcare providers, hospitals, clinics and nursing homes all across the Gulf Coast and throughout the State of Alabama.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2020 . SQI is a Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products fo

Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, announced today that it has signed a one year Clinical & Commercial Supply Agreement with AstraZeneca UK Ltd (“AstraZeneca”).

Arranta Bio (“Arranta”), the leading microbiome contract development and manufacturing organization (CDMO), today announced completion of its process development laboratory expansion project and a commitment to add additional early-clinical GMP capacity at its Center of Excellence for Microbiome Process Development and Early Clinical

International experts treating COVID-19 patients have concluded that hemodynamic optimization plays a major role in the management of the complex interaction of respiratory and cardiovascular factors.

The new locations for Tampa General Hospital Cancer Care will be TGH’s first locations on the east coast of Florida.

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Orphan Reach selected TransPerfect’s Trial Interactive cloud-based platform for remote site monitoring, eTMF, and mobile eTMF in support of a phase II COVID-19 study that received rapid MHRA start-up approval.

Life sciences R&D platform to expand product suite and fuel biotech breakthroughs tackling COVID-19 to cancer to climate change [28-May-2020] SAN FRANCISCO , May 28, 2020 /PRNewswire/ -- Benchling, the leading life sciences R&D cloud platform, announced it closed $50 million in Series D funding led by Alkeon and joined by new investors Spark Capital, Lux Cap

UNITY Biotechnology today announced the appointment of Anirvan Ghosh, Ph.D., as CEO and member of the Board of Directors, effective March 30, 2020.

DOD supercomputers virtually screen millions of drug compounds with SwRI’s Rhodium software